Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
87.80
-5.03 (-5.42%)
Mar 5, 2026, 4:00 PM EST - Market closed
Mesa Laboratories Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 247.54 | 240.98 | 216.19 | 219.08 | 184.34 | 133.94 | Upgrade
|
| Revenue Growth (YoY) | 4.12% | 11.47% | -1.32% | 18.85% | 37.63% | 13.81% | Upgrade
|
| Cost of Revenue | 93.06 | 88.88 | 81.71 | 85.39 | 75.25 | 46.92 | Upgrade
|
| Gross Profit | 154.48 | 152.1 | 134.48 | 133.69 | 109.09 | 87.01 | Upgrade
|
| Selling, General & Admin | 117.09 | 115.02 | 111.49 | 109.88 | 88.62 | 64.27 | Upgrade
|
| Research & Development | 20.16 | 19.52 | 19.3 | 20.49 | 15.77 | 10.39 | Upgrade
|
| Operating Expenses | 137.25 | 134.53 | 130.79 | 130.37 | 104.39 | 74.66 | Upgrade
|
| Operating Income | 17.23 | 17.57 | 3.69 | 3.32 | 4.7 | 12.36 | Upgrade
|
| Interest Expense | -10.62 | -11.86 | -5.7 | -4.77 | -3.89 | -8.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 8.71 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.26 | -1.4 | 2.12 | 1.06 | 2.76 | -2.03 | Upgrade
|
| EBT Excluding Unusual Items | 14.07 | 4.31 | 0.11 | -0.39 | 3.57 | 2.3 | Upgrade
|
| Merger & Restructuring Charges | - | -1.23 | -1.23 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | -156.89 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -117.64 | - | - | - | Upgrade
|
| Other Unusual Items | - | 2.89 | - | - | - | - | Upgrade
|
| Pretax Income | 14.07 | 5.96 | -275.65 | -0.39 | 3.57 | 2.3 | Upgrade
|
| Income Tax Expense | 10.33 | 7.94 | -21.4 | -1.32 | 1.7 | -0.97 | Upgrade
|
| Net Income | 3.73 | -1.97 | -254.25 | 0.93 | 1.87 | 3.27 | Upgrade
|
| Net Income to Common | 3.73 | -1.97 | -254.25 | 0.93 | 1.87 | 3.27 | Upgrade
|
| Net Income Growth | - | - | - | -50.29% | -42.85% | 84.14% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 | Upgrade
|
| Shares Change (YoY) | 1.51% | 0.65% | 0.47% | 0.49% | 4.12% | 17.23% | Upgrade
|
| EPS (Basic) | 0.68 | -0.36 | -47.20 | 0.17 | 0.36 | 0.66 | Upgrade
|
| EPS (Diluted) | 0.68 | -0.36 | -47.20 | 0.17 | 0.35 | 0.64 | Upgrade
|
| EPS Growth | - | - | - | -51.43% | -45.31% | 56.10% | Upgrade
|
| Free Cash Flow | 37.94 | 42.56 | 41.57 | 23.44 | 34.79 | 35.08 | Upgrade
|
| Free Cash Flow Per Share | 6.91 | 7.85 | 7.72 | 4.37 | 6.52 | 6.85 | Upgrade
|
| Dividend Per Share | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 | Upgrade
|
| Gross Margin | 62.41% | 63.12% | 62.20% | 61.02% | 59.18% | 64.97% | Upgrade
|
| Operating Margin | 6.96% | 7.29% | 1.70% | 1.52% | 2.55% | 9.23% | Upgrade
|
| Profit Margin | 1.51% | -0.82% | -117.61% | 0.43% | 1.01% | 2.44% | Upgrade
|
| Free Cash Flow Margin | 15.33% | 17.66% | 19.23% | 10.70% | 18.87% | 26.19% | Upgrade
|
| EBITDA | 42.25 | 42.1 | 35.26 | 36.45 | 29.77 | 30.02 | Upgrade
|
| EBITDA Margin | 17.07% | 17.47% | 16.31% | 16.64% | 16.15% | 22.41% | Upgrade
|
| D&A For EBITDA | 25.02 | 24.53 | 31.57 | 33.13 | 25.07 | 17.66 | Upgrade
|
| EBIT | 17.23 | 17.57 | 3.69 | 3.32 | 4.7 | 12.36 | Upgrade
|
| EBIT Margin | 6.96% | 7.29% | 1.70% | 1.52% | 2.55% | 9.23% | Upgrade
|
| Effective Tax Rate | 73.46% | 133.12% | - | - | 47.65% | - | Upgrade
|
| Revenue as Reported | 240.98 | 240.98 | 216.19 | 219.08 | 184.34 | 133.94 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.